Biogen expects $164M R&D charge to hit Q2 2026 earnings
Go back to Biogen expects $164M R&D charge to hit Q2 2026 earnings| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 223.30 -2.06 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.36 | 52 Week High | $333.65 | |||
| Open | $226.94 | 52 Week Low | $223.02 | |||
| Day High | $229.19 | P/E | 28.59 | |||
| Day Low | $222.36 | EPS | $7.81 | |||
| Volume | 398,384 | |||||

